Clariane SE (CHIX:CLARIP) Interest Received


CHIX:CLARIP Clariane SE CHIX:CLARIP
61 GF Score
Price €4.13
GF Value €2.47
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clariane SE Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

CHIX:CLARIP
61GF Score
Clariane SE CHIX:CLARIP
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clariane SE (CHIX:CLARIP) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.13 is trading 67% above its estimated GF Value™ of €2.47. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for CHIX:CLARIP:

  • Interest Received:
  • GF Value™: €2.47 vs. price of €4.13 (67% above fair value)
  • GF Score™: 61/100 with 9 warning signs

No single metric tells the full story. See the CHIX:CLARIP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score

Get the complete analysis for CHIX:CLARIP

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.13
Price
€2.47
GF Value